Array Biopharma Inc (NASDAQ:ARRY): Are Hedge Funds Right About This Stock?

Array Biopharma Inc (NASDAQ:ARRY) has experienced a decrease in support from the world’s most elite money managers in recent months.

If you’d ask most stock holders, hedge funds are seen as worthless, old investment tools of years past. While there are over 8000 funds in operation today, we hone in on the aristocrats of this group, close to 450 funds. It is estimated that this group oversees the lion’s share of the smart money’s total capital, and by paying attention to their highest performing investments, we have revealed a number of investment strategies that have historically beaten the broader indices. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 25 percentage points in 6.5 month (explore the details and some picks here).

Array Biopharma Inc (NASDAQ:ARRY)Just as beneficial, bullish insider trading activity is a second way to break down the world of equities. Obviously, there are plenty of incentives for an insider to cut shares of his or her company, but only one, very clear reason why they would buy. Many empirical studies have demonstrated the valuable potential of this tactic if shareholders understand what to do (learn more here).

Consequently, let’s take a peek at the latest action regarding Array Biopharma Inc (NASDAQ:ARRY).

What does the smart money think about Array Biopharma Inc (NASDAQ:ARRY)?

At year’s end, a total of 15 of the hedge funds we track were bullish in this stock, a change of -25% from one quarter earlier. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were increasing their holdings substantially.

According to our comprehensive database, Deerfield Management, managed by James E. Flynn, holds the largest position in Array Biopharma Inc (NASDAQ:ARRY). Deerfield Management has a $42 million position in the stock, comprising 2.3% of its 13F portfolio. On Deerfield Management’s heels is Samuel Isaly of OrbiMed Advisors, with a $16 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include Daniel Gold’s QVT Financial, Thomas E. Claugus’s GMT Capital and Julian Baker and Felix Baker’s Baker Bros. Advisors.

Judging by the fact that Array Biopharma Inc (NASDAQ:ARRY) has experienced a declination in interest from hedge fund managers, it’s safe to say that there lies a certain “tier” of hedgies that decided to sell off their positions entirely at the end of the year. Interestingly, Wayne Holman’s Ridgeback Capital Management dumped the largest position of all the hedgies we track, totaling close to $11 million in stock.. JΘr⌠me Pfund and Michael Sj÷str÷m’s fund, Sectoral Asset Management, also dumped its stock, about $9 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest dropped by 5 funds at the end of the year.

Insider trading activity in Array Biopharma Inc (NASDAQ:ARRY)

Insider buying is at its handiest when the company in question has experienced transactions within the past six months. Over the last half-year time period, Array Biopharma Inc (NASDAQ:ARRY) has seen zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

With the results demonstrated by the aforementioned strategies, everyday investors should always pay attention to hedge fund and insider trading activity, and Array Biopharma Inc (NASDAQ:ARRY) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!